NCT04309578 2024-02-28
A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Asan Medical Center
Phase 2 Unknown
Asan Medical Center
Trans Tasman Radiation Oncology Group
Shanghai Changzheng Hospital
Dong-A University Hospital
Seoul National University Bundang Hospital
Biotech Pharmaceutical Co., Ltd.
National Cancer Institute (NCI)
Rabin Medical Center
Gustave Roussy, Cancer Campus, Grand Paris